• Anne K Streit, Michael F Netter, Franca Kempf, Magdalena Walecki, Susanne Rinné, Murali K Bollepalli, Regina Preisig-Müller, Vijay Renigunta, Jürgen Daut, Thomas Baukrowitz, Mark S P Sansom, Phillip J Stansfeld, and Niels Decher.
• Institute for Physiology and Pathophysiology, Vegetative Physiology Group, University of Marburg, 35037 Marburg, Germany.
• J. Biol. Chem. 2011 Apr 22;286(16):13977-84.

AbstractTwo-pore domain potassium (K(2P)) channels play a key role in setting the membrane potential of excitable cells. Despite their role as putative targets for drugs and general anesthetics, little is known about the structure and the drug binding site of K(2P) channels. We describe A1899 as a potent and highly selective blocker of the K(2P) channel TASK-1. As A1899 acts as an open-channel blocker and binds to residues forming the wall of the central cavity, the drug was used to further our understanding of the channel pore. Using alanine mutagenesis screens, we have identified residues in both pore loops, the M2 and M4 segments, and the halothane response element to form the drug binding site of TASK-1. Our experimental data were used to validate a K(2P) open-pore homology model of TASK-1, providing structural insights for future rational design of drugs targeting K(2P) channels.

34 keywords...

hide…